In vivo biodistribution and toxicity depends on nanomaterial composition, size, surface functionalisation and route of exposure

Abstract

Anticipated growth of the nanotechnology industry has motivated the development of rapid, relevant and efficient testing strategies to evaluate the biological activity and toxic potential of the growing number of novel nanoparticles. Since nanoparticles may interact with biological systems in unforeseen ways, it is important that evaluation of nanomaterial–biological interactions cover a broad range of cell types, tissues, organs and systems. Here, we use the embryonic zebrafish as a dynamic whole animal (in vivo) assay to investigate the importance of chemical composition, size, surface functionalisation and route of exposure on nanomaterial–biological interactions and delineate nanomaterials that are biologically active from those that are not. Information gained using model systems, such as the embryonic zebrafish, can be used to direct the rational development of safer, less hazardous nanoparticles. Our results demonstrate the utility of this model as an effective and accurate tool to assess the biological activity and toxic potential of nanomaterials in a short period of time with minimal cost.